Teva Inks Texas Opioids Settlement And Eyes J&J’s Nationwide ‘Formula’

Israeli Giant Spells Out ~$3bn Nationwide Settlement Ambition; Wants Deal In 2022

 
• By Dean Rudge
  
3D rendering conceptual image of dollars, symbolizing the rising prices - Illustration
Teva wants existing shareholders to benefit once legal issues are settled • Source: Shutterstock: elsar
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin